April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Brief Pulses Of Ischemia Protect The Retina From Glaucomatous Damage
Author Affiliations & Notes
  • Nicolas A. Belforte
    Department of Human Biochemistry, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
  • Pablo Sande
    Department of Human Biochemistry, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
  • Monica Chianelli
    Department of Human Biochemistry, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
  • Ruth E. Rosenstein
    Department of Human Biochemistry, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships  Nicolas A. Belforte, None; Pablo Sande, None; Monica Chianelli, None; Ruth E. Rosenstein, None
  • Footnotes
    Support  Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), the University of Buenos Aires, and CONICET, Argentina
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3077. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nicolas A. Belforte, Pablo Sande, Monica Chianelli, Ruth E. Rosenstein; Brief Pulses Of Ischemia Protect The Retina From Glaucomatous Damage. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3077.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glaucoma is a neurodegenerative disorder which is triggered by different factors including mechanical stress due to increased intraocular pressure (IOP), glutamate excitotoxicity, oxidative stress, and ischemia and reperfusion injury, among others. Retinal ischemia impairs retinal neuronal energy metabolism, by launching a reactions cascade resulting in cell death. Although there is no effective treatment against retinal ischemic injury, it is possible to activate an endogenous protection mechanism (ischemic tolerance) by ischemic preconditioning (IPC) or postconditioning (PostC). We investigated the effect of a weekly application of brief retinal ischemia pulses (ischemic conditioning) on retinal damage provoked by experimental glaucoma induced by weekly injections of chondroitin sulphate (CS).

Methods: : Weekly bilateral injections of CS were performed in the eye anterior chamber of male Wistar rat for 10 weeks. Retinal ischemia was induced by increasing IOP to 120 mmHg for 5 min; this maneuver started 6 weeks after a weekly treatment with CS, and was weekly repeated in one eye while the contralateral eye was submitted to a sham procedure. At 10 weeks of treatment with CS, IOP was assessed with a TonoPen XL, ERGs were registered under scotopic conditions, and flash visual evoked potentials (VEPs) were registered with skull-implanted electrodes, while retinal morphology was examined by optical microscopy and immunohistochemistry (with an anti NeuN-antibody). Thiobarbituric acid reactive substances (TBARS) levels were measured as an index of lipid peroxidation.

Results: : Brief ischemia pulses, which did not affect the increase in IOP induced by CS, reversed the effect of chronic ocular hypertension on ERG and VEPs. Moreover, a significant preservation in the number of NeuN positive retinal ganglion cells was observed in the retina from hypertensive eyes exposed to ischemia pulses. An increase in lipid peroxidation was observed in the retina form eyes injected with CS, whereas ischemia pulses decreased this parameter.

Conclusions: : These results indicate that induction of ischemic tolerance could constitute a fertile avenue for the development of new therapeutic strategies in glaucoma treatment.

Keywords: ischemia • neuroprotection • ganglion cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×